Pharmacy, Microbiology & Environmental Services: Engaging Critical Partners Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.

Slides:



Advertisements
Similar presentations
Creating vital partnerships between: Children Home School Community.
Advertisements

Medication Management
Safety Committee Orientation Environmental Energy Technologies Division November 18, 2011.
By Prof. OSSAMA RASSLAN Secretary General, Egyptian Society of Infection Control.
Interdisciplinary Care PO 007
Principles of Standards and Measures
Healthcare Emergency Coalitions: An Ebola Preparedness Perspective Michael Clark, MD J. Marc Liu, MD, MPH Medical Advisors-Wisconsin Hospital Emergency.
HICC An Infection Control Committee provides a forum for multidisciplinary input and cooperation, and information sharing This committee should include.
August 2013 School of Medicine Strategic Planning Community Engagement Committee.
Drug Utilization Review (DUR)
Hospital Pharmacy Payam Parchamazad, PharmD Staff Pharmacist
Growing a New Culture: Patient Safety Nancy Brumley Gessling, MSN, CIC Infection Prevention Copper Basin Medical Center.
APIC-VIRGINIA STRATEGIC PLAN VISION : It is the vision of APIC-VA to be the leader, key resource and advocate in the field of infection prevention.
Implementation of a Hospital Paediatric Antimicrobial Stewardship Program Sydney Children’s Hospital Mostaghim M, Snelling T, McMullan B, Palasanthiran.
Ebola Facts October 15, 2014.
Infection Prevention and Control Competencies for Healthcare Personnel Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.
Increasing Your Infection Prevention Capacity Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases University of Louisville.
Preventing Transmission of MRSA in the Hospital Setting Patricia A. Pearson RN, CIC Infection Prevention & Control Synergy / St. Joseph’s Hospital.
Essential Components of Your Infection Prevention and Control Manual Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.
[Hospital Name | Presenter name and title | Date of presentation]
TBS November 4, |1 | AMR and appropriate use of antimicrobials Nicola Magrini and Jane Robertson Policy, Access and Use Team, EMP TBS 4 November.
CCC Team Assessment of Care Coordination Capacity February 26, 2014 Care Coordination Collaborative California Institute for Mental Health Care Coordination.
Innovative Use of Electronic Hand Hygiene Monitoring to Control a Clostridium difficile cluster on a Hematopoietic Stem Cell Transplant Unit Natasha Robinson.
Laboratory Training for Field Epidemiologists Strengthening Laboratory and Epidemiology Collaboration Introduction May 2007.
How to Start an Antimicrobial Stewardship Program
Adair County System of Care Overcoming Obstacles to Helping Others.
JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.
Module 3. Session DCST Clinical governance
Preparing for Vaccine Administration: Warnings, Precautions and Contraindications Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious.
1 DoD-VA Partnership Status 22 February DoD/VA Partnership DoD/VA Mission, Vision, Authority DoD/VA Council Structure Joint Strategic Plan Current.
Primary Care Workforce Summit November 29, 2012 Country Springs Hotel, Waukesha Primary Care Workforce Summit Pharmacy Perspective Kate Hartkopf, PharmD.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Antimicrobial Stewardship St. Mary’s Hospital Infection Control Committee.
Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.
Infection Control Clinical Pharmacy and Patient Safety
Global Foodborne Infections Network (GFN) Building capacity to detect, control and prevent foodborne and other enteric infections from farm to table National.
CDI Prevention in Long Term Care Collaborative Welcome and Project Overview Deborah Quetti RN, MBA, BSN, CPHQ April 9, 2014.
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
The Purchase and Implementation of Smart Infusion Pump Technology: Lessons Learned at a Multi-Hospital System Deborah Christopher, BSN, RN, Six Sigma Black.
Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.
BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002.
Documentation, Registries and Performance Improvement Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases University of Louisville.
Training structure Safety and good quality work Module 1: Knowledge about Ebola Virus Disease Support from the community Support from the hospital.
Emtenan AlHarbi,Mcs Clinical pharmacist
Essential Resources for the Infection Preventionist Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases University of Louisville.
1 SHARED LEADERSHIP: Parents as Partners Presented by the Partnership for Family Success Training & TA Center January 14, 2009.
EBOLA GRANT WORK PLAN. Overview Region received: $258,238 Project Period: May 18, 2015-May 17, 2020 MN will call this EBP for Ebola Budget Period Requirements:
A Team Members Guide to a Culture of Safety
HIV/STD Partner Services Recommendations Cindy Getty & Rheta Barnes Divisions of HIV/AIDS Prevention & STD Prevention National Centers for HIV/AIDS, Viral.
Eshley May Pacamalan University of Central Florida.
Pharmacists’ Patient Care Process
TB infection control and prevention of XDR Group II.
Copyright © 2008 Delmar Learning. All rights reserved. Unit 2 Role of the Nursing Assistant.
AHRQ Safety Program for Long-Term Care: HAIs/CAUTI Long-Term Care Safety Toolkit: Building a Culture of Safety National Content Webinar April 16, 2015.
Learning Outcomes Discuss current trends and issues in health care and nursing. Describe the essential elements of quality and safety in nursing and their.
National Patient Safety Goals 2008 T he University of Toledo Medical Center Toledo, Ohio.
Canadian Best Practice Recommendations for Stroke Care Recommendation 1: Public Awareness and Patient Education (Updated 2008)
Quality & Safety Candace C. Cherrington, PhD, RN Associate Professor.
Antimicrobial Stewardship
Antibiotics: handle with care!
HEALTH PROMOTION.
The AHRQ Safety Program for Improving Antibiotic Use
Disaster Response – A Collaboration
This is an archived document.
The AHRQ Safety Program for Improving Antibiotic Use
Managing Challenging Patient Behaviors
Hospital Antibiotic Stewardship Programs
Essential Drugs and Medicines Policy
Essential Drugs and Medicines Policy
Ebola Facts October 15, 2014.
Presentation transcript:

Pharmacy, Microbiology & Environmental Services: Engaging Critical Partners Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases University of Louisville

Objectives Review aspects of critical partnerships in addressing the challenges of infection prevention Identify methods to engage those partners and capitalize on individual and combined strengths

Current Realities in Infection Prevention Emerging Infection Rapid Detection of organisms Impact on the Environment Response to Pathogens Staff Training and Education

Interdependence Preventing Infection

Interdependence Preventing Infection Pathogen Detection

Interdependence Preventing Infection Pathogen Detection Pathogen Treatment

Interdependence Preventing Infection Pathogen Detection Pathogen Eradication Pathogen Treatment

Interdependence Preventing Infection Pathogen Detection PathogenEradication Pathogen Treatment Rapid detection Rapid communication Reporting Feedback

Interdependence Preventing Infection Pathogen Detection PathogenEradication Pathogen Treatment Drug selection Drug use Investigation Feedback Rapid detection Rapid communication Reporting Feedback

Interdependence Preventing Infection Pathogen Detection PathogenEradication Pathogen Treatment Drug selection Drug use Investigation Feedback Rapid detection Rapid communication Reporting Feedback Product Use Staff performance Process efficacy Local engagement Feedback

Current Urgent Issue CRE – Emerging pathogen – Detection challenging – Treatment options are limited – Persistent in the environment – Rapid isolation necessary – Communication internally and externally – Staff performance critical

Collaborative Efforts Recognizing the interdependence Shared responsibilities Shared mission and vision Mutual respect Communication Support

Infection Control Committee Action or reporting function Premise should be “no free lunch” Every member or attendee has a specific purpose Provide information and develop interventions Evaluate effectiveness Determine course adjustments Enable the facility to be nimble in responses Feedback methods

How does your facility integrate infection control reporting of activities? A.We have a specific infection control committee B.Infection control included in the performance improvement committee C.Infection control included in the patient safety committee D.Do not know E.Other process used

How does your facility committee function? A.It is only a place for reporting B.It is only a place for developing action plans C.If is a combination of reporting and action D.Do not know E.Other

How is microbiology information shared ? A.In the committee B.Not part of the committee process C.Do not know D.Other process used

How is pharmacy information shared ? A.In the committee B.Not part of the committee process C.Do not know D.Other process used

How is environmental services information shared ? A.In the committee B.Not part of the committee process C.Do not know D.Other process used

Pharmacy Reports Antimicrobial utilization outside of guidelines – Dose, duration, timing Variation in antimicrobial use – Outside formulary, new additions, non-traditional use Pharmacy and Therapeutics Committee updates – Formulary updates/revisions – Discussion of new agents Performance improvement initiatives Antimicrobial utilization outside of guidelines – Dose, duration, timing Variation in antimicrobial use – Outside formulary, new additions, non-traditional use Pharmacy and Therapeutics Committee updates – Formulary updates/revisions – Discussion of new agents Performance improvement initiatives

Microbiology Reports Organisms of interest Emerging pathogens Antibiograms Report adjustments (e.g., susceptibilities) New/alterations in testing methods Performance improvement initiatives Organisms of interest Emerging pathogens Antibiograms Report adjustments (e.g., susceptibilities) New/alterations in testing methods Performance improvement initiatives

Environmental Reports Current environmental hygiene approaches Current disinfectants used Products under evaluation Employee health issues Environmental situations (e.g., construction, water damage) Performance improvement initiatives Current environmental hygiene approaches Current disinfectants used Products under evaluation Employee health issues Environmental situations (e.g., construction, water damage) Performance improvement initiatives

Active Engagement Case Scenario 64 year old female, identified with CRE in her urine. Patient is symptomatic with elevated temperature and CRE was identified in a urine culture. How can we expect that pharmacy, microbiology, and environmental services will be working together with infection prevention and control on this issue?

Active Engagement Carbapenem-resistant Enterobacteriaceae (CRE) – Pharmacy Current treatment options Obtaining medication Ensuring appropriate use of the selected agents Intervening when treatment outside guidelines Feedback of results of appropriate use and interventions Identification of treatment failures

Active Engagement Carbapenem-resistant Enterobacteriaceae (CRE) – Pharmacy – Why is this important to infection control? Additional way to identify cases Overall adherence with infection prevention activities Opportunity to heighten impact of infection prevention Identification of educational needs – New drug, new methods for administration? – What will administering staff need to know? – Who else needs to be involved (e.g., IV therapy team?)

Active Engagement Carbapenem-resistant Enterobacteriaceae (CRE) – Microbiology Current detection methods New methods or improvements Ensuring appropriate sample collection Feedback of results Feedback of results and how collection methods impacted results Identification of trends

Active Engagement Carbapenem-resistant Enterobacteriaceae (CRE) – Microbiology – Why is this important to infection control? Additional way to identify cases Overall adherence with infection prevention activities Opportunity to heighten impact of infection prevention Identification of educational needs – Specimen collection – Recognition of the abnormal – Responding to the abnormal – Reflexive implementation of control and containment methods

Active Engagement Carbapenem-resistant Enterobacteriaceae (CRE) – Environmental Services Current cleaning and disinfection methods Current disinfectants used Changing methods or agents Staff performance Feedback of results Identification of trends

Active Engagement Carbapenem-resistant Enterobacteriaceae (CRE) – Environmental Services – Why is this important to infection control? Staff performance Who else assists with environmental hygiene Overall adherence with infection prevention activities Opportunity to heighten impact of infection prevention Identification of educational needs – Cleaning and disinfection processes – Who else can help – Barriers to environmental hygiene – Understanding the impact of current pathogens – Transmission issues – Patient and family involvement

Objectives Review aspects of critical partnerships in addressing the challenges of infection prevention Identify methods to engage those partners and capitalize on individual and combined strengths